Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Orchard Therapeutics plc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 61 | 2 | 50 | −9 |
| Shares | 54.6M | 22.7K | 51.8M | −2.85M (−5.2%) |
| Value | $38.9M | $16.0K | $30.2M | −$8.65M (−22.2%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (8)
Institutions that held Orchard Therapeutics plc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 2,000,000 | $1.17M | 0.18% |
| UBS Oconnor LLC | 1,093,924 | $639.0K | 0.01% |
| Acadian Asset Management LLC | 261,683 | $153.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 226,271 | $132.0K | 0.00% |
| Millennium Management LLC | 181,459 | $106.0K | 0.00% |
| Two Sigma Investments, LP | 20,035 | $12.0K | 0.00% |
| HighTower Advisors, LLC | 12,000 | $7.00K | 0.00% |
| Simplex Trading, LLC | 870 | $0 | 0.00% |
Sold out (17)
Institutions that held Orchard Therapeutics plc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| SG Americas Securities, LLC | 1,052,786 | $750.0K |
| Eversept Partners, LP | 419,581 | $298.7K |
| Harbor Capital Advisors, Inc. | 236,681 | $168.0K |
| Hennion & Walsh Asset Management, Inc. | 164,178 | $117.0K |
| Ikarian Capital, LLC | 155,606 | $110.0K |
| Legal & General Group Plc | 81,422 | $58.0K |
| Goldman Sachs Group Inc | 36,794 | $26.0K |
| HRT Financial LP | 25,989 | $18.0K |
| Brewin Dolphin Ltd | 19,500 | $14.0K |
| JustInvest LLC | 16,259 | $12.0K |
| Two Sigma Advisers, LP | 15,900 | $11.0K |
| Boothbay Fund Management, LLC | 14,932 | $11.0K |
| US Bancorp | 9,236 | $7.00K |
| Aquatic Capital Management LLC | 3,800 | $3.00K |
| Quantbot Technologies LP | 3,300 | $2.00K |
| Steward Partners Investment Advisory, LLC | 1,000 | $1.00K |
| Beaird Harris Wealth Management, LLC | 120 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held Orchard Therapeutics plc at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Golden State Equity Partners | 22,550 | $16.0K |
| Dixon Hughes Goodman Wealth Advisors LLC | 125 | $0 |